Anti-cancer drug price regulation in India: Financial implications and annual savings to patients

Neoadjuvant chemotherapy with CapeOx alone vs standard chemoradiotherapy (CRT) with Capecitabine for patients with LARC

Giredestrant plus palbociclib vs anastrozole plus palbociclib for post-menopausal, HER2-negative, untreated early breast cancer

Novel therapies in multiple myeloma

OncoAlert and ecancer - ESMO 2021 Day 4

Disparities in myeloma: Closing the gap

Abiraterone acetate plus prednisolone added to ADT + docetaxel, gives 25% reduction in risk of death compared to ADT + docetaxel alone in prostate cancer

OncoAlert and ecancer - ESMO 2021 Day 3

STAR: First-line sunitinib or pazopanib for locally advanced and/or metastatic renal cancer

Nivolumab with alternatively scheduled ipilimumab in first-line treatment of advanced RCC

First-line CDK 4/6 inhibition shows OS benefit for metastatic breast cancer

KEYNOTE-355: First-line pembrolizumab plus chemotherapy for metastatic triple-negative breast cancer